Patent Portfolio

Nucleic acid medicine for hereditary motor and sensory neuropathy with proximal dominant involvement

Ref. No. AJ307
Appl. No.
(filing date)
PCT/JP2026/010029(2026/3/13)
Pub. No.
(Pub. date)
WO2026/192068(2026/9/17)
Priority claim No.
(Priority date)

JP2025-041887(2025/03/14)

Inventor INOUE Haruhisa, et al.
Assignee Kyoto University
Title of Invention Nucleic acid medicine for hereditary motor and sensory neuropathy with proximal dominant involvement
Abstract

The present invention relates to an antisense oligonucleotide that suppresses the expression level of the TRK-fused gene (TFG), and to its use.

Comments

The antisense oligonucleotide (ASO) of the present invention can effectively reduce the expression levels of TFG—specifically, human TFG—mRNA and protein.